Capsule Endoscopy System Tech Support Promo Box
Technical support
Get technical support for all endoscopy products.
Email us
Phone UK & IE: +44 1923 201860
RF ablation systems
<p>Indicated for use for the coagulation of bleeding and non-bleeding sites in the gastrointestinal tract including, but not limited to, Barrett’s esophagus.</p>
Progression of Barrett’s esophagus to esophageal adenocarcinoma (EAC) can be deadly.2 Surveillance may not be enough for some patients.
Clinical data has identified several risk factors that contribute to disease progression, including2:
Eradicate Barrett’s esophagus for patients with low-grade dysplasia and reduce the relative risk of disease progression to high-grade dysplasia and esophageal adenocarcinoma by up to 94% with the Barrx™ radiofrequency ablation system.†,4,5,6
Major GI societies endorse radiofrequency ablation in the treatment guidelines for Barrett’s esophagus. With demonstrated efficacy, safety,1 and support from leading institution7,8 this technology allows you to act with confidence.
When risk of progression is high, proactively treat with the Barrx™ radiofrequency ablation system.
Our comprehensive solutions can assist you in the assessment and treatment of esophageal patients.
Find patient information about Barrett's esophagus, GERD, acid reflux, and related treatments and therapies.
| Item number | Description | Units per box |
|---|---|---|
| 1190A-115A | Barrx™ Flex RFA Energy Generator, 115V. Contains 1 Barrx™ flex RFA footswitch and 1 Barrx™ flex RFA output cable included with each generator. |
1 |
| 1190A-230A | Barrx™ flex RFA energy generator, 230V. Contains 1 Barrx™ flex RFA footswitch and 1 Barrx™ flex RFA output cable included with each generator. |
1 |
| FLEXFS-010A | Barrx™ flex RFA footswitch, 10' (3 m) | 1 |
| FLEXCC-020A | Barrx™ flex RFA output cable, 9' (2.7 m) | 1 |
† 94% is the calculated relative risk reduction [(26-1.5)/26] = 25/26 100. From [25.0% (1.5% for ablation versus 26.5% for control; 95%CI, 14.1%–35.9%; P < .001].
You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the United Kingdom.